Generation Bio (GBIO)
(Delayed Data from NSDQ)
$2.54 USD
-0.09 (-3.42%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $2.54 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.28 | 0.00% |
Earnings Summary
For their last quarter, Generation Bio (GBIO) reported earnings of -$0.31 per share, missing the Zacks Consensus Estimate of -$0.27 per share. This reflects a negative earnings surprise of 14.81%. Look out for GBIO's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.28 per share, reflecting a year-over-year increase of 34.88%.
Earnings History
Price & Consensus
Zacks News for GBIO
Protagonist Therapeutics (PTGX) Reports Q2 Loss, Misses Revenue Estimates
GBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services